Home › Inflammatory Bowel Disease › Kansas
Inflammatory Bowel Disease clinical trials in Kansas
3 studies for Inflammatory Bowel Disease are looking for participants at sites in Kansas.
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
- Site 006, Kansas City
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Sep 29, 2026 · NCT07012395Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- University of Kansas Clinical Research Center, Fairway
- HaysMed, Hays
- University of Kansas Cancer Center, Kansas City
- and 7 more
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT03816345BOOM-IBD2 Pivotal Clinical Trial
- Kansas Gastro, Wichita
Recruiting
Ages 18 to 85 · All sexes · Updated Aug 6, 2026 · NCT06571669From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.